PENNANTPARK INVESTMENT CORP
PNNTAnalytical Summary
PENNANTPARK INVESTMENT CORP shows mixed fundamentals. Further due diligence is recommended before making investment decisions.
22-Year Financial Trajectory
QuarterlyHealth Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-K ↗ | Q3 FY2025 Jun 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q3 FY2024 Jun 30, 2024 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Dec 31, 2023 10-Q ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ | Q3 FY2023 Jun 30, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Dec 31, 2022 10-Q ↗ | Q4 FY2022 Sep 30, 2022 10-K ↗ | Q3 FY2022 Jun 30, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Dec 31, 2021 10-Q ↗ | Q4 FY2021 Sep 30, 2021 10-K ↗ | Q4 FY2020 Sep 30, 2020 10-K ↗ | Q4 FY2019 Sep 30, 2019 10-K ↗ | Q4 FY2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Growth YoY (%) | N/M |
-44.3%
Weak
↓
Weak
Declining
Year-over-year change in net income |
N/M |
117.6%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-41.2%
Weak
↓
Weak
Declining
Year-over-year change in net income |
51.0%
Excellent
↓
Excellent
Declining
Year-over-year change in net income |
49.8%
Excellent
↓
Excellent
Declining
Year-over-year change in net income |
-82.1%
Weak
Weak
Year-over-year change in net income |
230.2%
Excellent
Excellent
Year-over-year change in net income |
N/M | N/M | N/M |
54.2%
Excellent
Excellent
Year-over-year change in net income |
N/M | — | — | — | — | — | — | — | — |
| FCF Growth YoY (%) |
-74.4%
Weak
Weak
Year-over-year change in free cash flow |
— | — | N/M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-K ↗ | Q3 FY2025 Jun 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q3 FY2024 Jun 30, 2024 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Dec 31, 2023 10-Q ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ | Q3 FY2023 Jun 30, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Dec 31, 2022 10-Q ↗ | Q4 FY2022 Sep 30, 2022 10-K ↗ | Q3 FY2022 Jun 30, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Dec 31, 2021 10-Q ↗ | Q4 FY2021 Sep 30, 2021 10-K ↗ | Q4 FY2020 Sep 30, 2020 10-K ↗ | Q4 FY2019 Sep 30, 2019 10-K ↗ | Q4 FY2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
-15.62x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
15.02x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
111.81x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
6.31x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
15.06x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.17x
Fair
↑
Fair
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.25x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-4.50x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
-14.56x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
8.74x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
0.13x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.30x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
10.13x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
84.53x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
-6.95x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-K ↗ | Q3 FY2025 Jun 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q3 FY2024 Jun 30, 2024 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Dec 31, 2023 10-Q ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ | Q3 FY2023 Jun 30, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Dec 31, 2022 10-Q ↗ | Q4 FY2022 Sep 30, 2022 10-K ↗ | Q3 FY2022 Jun 30, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Dec 31, 2021 10-Q ↗ | Q4 FY2021 Sep 30, 2021 10-K ↗ | Q4 FY2020 Sep 30, 2020 10-K ↗ | Q4 FY2019 Sep 30, 2019 10-K ↗ | Q4 FY2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
-0.5%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.0%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-0.2%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.7%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.9%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.3%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.7%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
0.8%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.2%
Weak
→
Weak
Stable
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.1%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— |
4.2%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.0%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-14.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — | — | — | — | — | — |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-K ↗ | Q3 FY2025 Jun 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q3 FY2024 Jun 30, 2024 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Dec 31, 2023 10-Q ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ | Q3 FY2023 Jun 30, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Dec 31, 2022 10-Q ↗ | Q4 FY2022 Sep 30, 2022 10-K ↗ | Q3 FY2022 Jun 30, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Dec 31, 2021 10-Q ↗ | Q4 FY2021 Sep 30, 2021 10-K ↗ | Q4 FY2020 Sep 30, 2020 10-K ↗ | Q4 FY2019 Sep 30, 2019 10-K ↗ | Q4 FY2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt (USD) | — | — | $-51.78M | $-70.55M | — | $-55.85M | $-49.86M | — | $-35.42M | $-36.89M | — | $-42.78M | $-63.13M | $-28.56M | — | — | — | — | $-20.36M | — | — | — |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-K ↗ | Q3 FY2025 Jun 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q3 FY2024 Jun 30, 2024 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Dec 31, 2023 10-Q ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ | Q3 FY2023 Jun 30, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Dec 31, 2022 10-Q ↗ | Q4 FY2022 Sep 30, 2022 10-K ↗ | Q3 FY2022 Jun 30, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Dec 31, 2021 10-Q ↗ | Q4 FY2021 Sep 30, 2021 10-K ↗ | Q4 FY2020 Sep 30, 2020 10-K ↗ | Q4 FY2019 Sep 30, 2019 10-K ↗ | Q4 FY2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Equity (USD) | $439.23M | $457.23M | $463.95M | $480.58M | $488.11M | $494.32M | $493.91M | $491.22M | $501.53M | $499.14M | — | $503.62M | $495.71M | $502.91M | — | — | — | — | $660.14M | — | — | — |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-K ↗ | Q3 FY2025 Jun 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q3 FY2024 Jun 30, 2024 10-Q ↗ | Q2 FY2024 Mar 31, 2024 10-Q ↗ | Q1 FY2024 Dec 31, 2023 10-Q ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ | Q3 FY2023 Jun 30, 2023 10-Q ↗ | Q2 FY2023 Mar 31, 2023 10-Q ↗ | Q1 FY2023 Dec 31, 2022 10-Q ↗ | Q4 FY2022 Sep 30, 2022 10-K ↗ | Q3 FY2022 Jun 30, 2022 10-Q ↗ | Q2 FY2022 Mar 31, 2022 10-Q ↗ | Q1 FY2022 Dec 31, 2021 10-Q ↗ | Q4 FY2021 Sep 30, 2021 10-K ↗ | Q4 FY2020 Sep 30, 2020 10-K ↗ | Q4 FY2019 Sep 30, 2019 10-K ↗ | Q4 FY2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $-2.33M | $8.96M | $-964.00K | $8.15M | $9.46M | $16.08M | $18.37M | $3.75M | $16.09M | $10.65M | $12.27M | $20.95M | $4.87M | $-71.89M | $-34.93M | $-18.48M | $3.16M | $25.51M | — | — | — | — |
| Operating Cash Flow (USD) | $36.38M | $134.54M | $-107.79M | $51.46M | $142.36M | $18.75M | $-4.66M | $-16.87M | — | $-155.12M | $107.22M | — | — | $-9.61M | $80.19M | $-187.24M | $267.10M | $-177.35M | — | — | — | — |
Secondary lens
Benchmark Lens
Compare PNNT against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare PNNT against peers after checking the statement evidence.
Percentile Rankings
How PNNT compares to all companies
Compare PNNT with peers
Stack PNNT against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 8 years · 22 quarters